Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 3, 1998, Pages 665-675

  Lelas, Snjezana ^a   Gerak, Lisa R ^a   Landers, Laura K ^a   Brandt, Michael R ^a   Bagley, Jerome R ^b   Brockunier, Linda L ^b   France, Charles P ^a,c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Ohmeda Inc   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Antinociception; Drug discrimination; Mirfentanil; OHM10579; Respiration; Rhesus monkey

Indexed keywords

FENTANYL; MIRFENTANIL; MIRFENTANIL DERIVATIVE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; NALTREXONE; OHM 10579; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BREATHING; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG MECHANISM; FEMALE; HYPERVENTILATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RHESUS MONKEY;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; DEUTERIUM; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; MACACA MULATTA; MALE; NALBUPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RESPIRATORY MECHANICS;

EID: 0031858417     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00046-X     Document Type: Article

References (17)

1. Bagley, J. R.; Wynn, R. L.; Rudo, F. G.; Doorley, B. M.; Spencer, H. K.; Spaulding, T.: New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/ or antagonist properties. J. Med. Chem. 32:663-670; 1989.
2. Byrd, L. D.: Contrasting effects of morphine on schedule-controlled behavior in the chimpanzee and baboon. J. Pharmacol. Exp. Ther. 193:861-869; 1975.
3. Dourish, C. T.; Greenshaw, A. J.; Boulton, A. A.: Deuterium substitution enhances the effects of beta-phenylethylamine on spontaneous motor activity in the rat. Pharmacol. Biochem. Behav. 19:471-475; 1983.
4. France, C. P.; Winger, G.; Medzihradsky, F.; Seggel, M. R.; Rice, K. C.; Woods, J. H.: Mirfentanil: Pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. J. Pharmacol. Exp. Ther. 258:502-510; 1991.
5. France, C. P.; Winger, G.; Medzihradsky, F.; Smith, C. B.; Woods, J. H.; Seggel, M.; Rice, K.: In vitro and in vivo characterization of a fentanyl-related compound with opioid agonist and antagonist effects. In: van Ree, J. M.; Mulder, A. H.; Wiegant, V. M.; van Wimersma Greidanus, T. B., eds. New leads in opioid research. Amsterdam: Excerpta Medica; 1990:71-72.
6. France, C. P.; Woods, J. H.: Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther. 250:937-943; 1989.
7. France, C. P; Woods, J. H.: Respiratory effects of receptor-selective opioids in rhesus monkeys. In: Quirion, R.; Jhamanadas, K.; Gianoulakis, C., eds. Progress in clinical and biological research: The international narcotics research conference (INRC) 1989, vol. 328. New York: Alan R. Liss; 1990:295-298.
8. Gerak, L. R.; France, C. P.: Discriminative stimulus effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 276:523-531; 1996.
9. Howell, L. L.; Bergman, J.; Morse, W. H.: Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J. Pharmacol. Exp. Ther. 245:364-372; 1988.
10. Lehmann, L. J.; DeSio, J. M.; Radvany, T.; Bikhazi, G. B.: Transdermal fentanyl in postoperative pain. Regul. Anesth. 22:24-28; 1997.
11. Miser, A. W.; Narang, P. K.; Dothage, J. A.; Young, R. C.; Sindelar, W.; Miser, J. S.: Transdermal fentanyl for pain control in patients with cancer. Pain 37:15-21; 1989.
12. Poklis, A.: Fentanyl: A review for clinical and analytical toxicologists. J. Toxicol. Clin. Toxicol. 33:439-447; 1994.
13. Salomaki, T. E.; Kokki, H.; Turunen, M.; Havukainen, U.; Nuutinen, L. S.: Introducing epidural fentanyl for on-ward pain relief after major surgery. Acta Anaesthesiol. Scand. 40:704-709; 1996.
14. Sandler, A. N.; Baxter, A. D.; Katz, J.; Samson, B.; Friedlander, M.; Norman, P.; Koren, G.; Roger, S.; Hull, K.; Klein, J.: A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory and pharmacokinetic effects. Anesthesiology 81:1169-1180; 1994.
15. van den Hoogen, R. H.; Colpaert, F. C.: Respiratory effects of morphine in awake unrestrained rats. J. Pharmacol. Exp. Ther. 237:252-259; 1986.
16. Woods, J. H.; Medzihradsky, F.; Smith, C. B.; Winger, G. D.; France, C. P.: Evaluation of new compounds for opioid activity. In: Harris, L., ed, Proceedings of the Committee on Problems of Drug Dependence, National Institute on Drug Abuse Research Monograph, vol. 105. Washington, DC: U.S. Government Printing Office; 1990:682-724.
17. Wynn, R. L.; Bagley, J. R.; Spencer, H. K.; Spaulding, T. C.: Evaluation of the morphine reversal actions and antinociceptive activity of a new class of opiate antagonists structurally related to fentanyl. Drug Dev. Res. 22:189-195; 1991.